Pascal and Francis Bibliographic Databases

Help

Export

Selection :

Permanent link
http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26700513

Adjunctive Oral Ziprasidone in Patients With Acute Mania Treated With Lithium or Divalproex, Part 2: Influence of Protocol-Specific Eligibility Criteria on Signal Detection

Author
SACHS, Gary S1 2 ; VANDERBURG, Douglas G3 ; EDMAN, Suzanne2 ; KARAYAL, Onur N4 ; KOLLURI, Sheela5 ; BACHINSKY, Mary7 ; CAVUS, Idil6
[1] Massachusetts General Hospital, United States
[2] Concordant Rater Systems, Boston, United States
[3] Medicines Development Group, , Pfizer Inc, United States
[4] Specialty Neuroscience, Pfizer Inc, United States
[5] Statistics (Specialty Care), Pfizer Inc, New York, New York, United States
[6] Specialty Care Neuroscience, Pfizer Inc, United States
[7] Medicines Development Group, Pfizer Inc, Groton, Connecticut, United States
Source

The Journal of clinical psychiatry. 2012, Vol 73, Num 11, pp 1420-1425, 6 p ; ref : 11 ref

ISSN
0160-6689
Scientific domain
Cognition; Psychology, psychopathology, psychiatry
Publisher
Physicians Postgraduate Press, Memphis, TN
Publication country
United States
Document type
Article
Language
English
Keyword (fr)
Aigu Anticonvulsivant Antipsychotique atypique Critère Détection signal Homme Lithium Manie Neuroleptique Normothymique Psychophysique Psychotrope Traitement Valproate semisodique Voie orale Ziprasidone Antagoniste Dérivé de la pipérazine Récepteur dopaminergique D2 Récepteur sérotoninergique 5-HT2 Trouble de l'humeur
Keyword (en)
Acute Anticonvulsant Atypical antipsychotic Criterion Signal detection Human Lithium Mania Neuroleptic Mood stabilizer Psychophysics Psychotropic Treatment Valproate semisodium Oral administration Ziprasidone Antagonist Piperazine derivatives D2 Dopamine receptor 5-HT2 Serotonine receptor Mood disorder
Keyword (es)
Agudo Anticonvulsivante Antipsicótico atípico Criterio Detección señal Hombre Litio Mania Neuroléptico Estabilizador humor Psicofísica Psicotropo Tratamiento Valproato semisódico Vía oral Ziprasidona Antagonista Piperazina derivado Receptor dopaminérgico D2 Receptor serotoninérgico 5-HT2 Trastorno humor
Classification
Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B02 Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02B Neuropharmacology / 002B02B03 Psycholeptics: tranquillizer, neuroleptic.

Pascal
002 Biological and medical sciences / 002B Medical sciences / 002B18 Psychopathology. Psychiatry / 002B18C Adult and adolescent clinical studies / 002B18C07 Mood disorders / 002B18C07B Mania

Francis
770 Psychology. Psychoanalysis. Psychiatry / 770-D Psychopathology. Psychiatry / 770-D03 Adult and adolescent clinical studies / 770-D03G Mood disorders / 770-D03G02 Mania

Francis
770 Psychology. Psychoanalysis. Psychiatry / 770-E Psychopharmacology / 770-E02 Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer…

Francis
770 Psychology. Psychoanalysis. Psychiatry / 770-E Psychopharmacology / 770-E03 Psycholeptics: tranquillizer, neuroleptic…

Discipline
Pharmacological treatments Psychopathology. Psychiatry. Clinical psychology
Origin
Inist-CNRS
Database
FRANCIS ; PASCAL
INIST identifier
26700513

Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS

Access to the document

Searching the Web